AI Health Technology Limited (01715) released its monthly return for the period ended 31 January 2026. The authorized share capital remained at HKD 150,000,000, with 150,000,000,000 ordinary shares at a par value of HKD 0.001 per share. The number of issued shares stayed at 360,759,879, and no treasury shares were held at the end of the month.

The company confirmed compliance with the public float requirement of 25%. There was no new share issuance or any exercise of share options during the period. A total of 6,000,000 previously outstanding share options were reduced to zero by the end of January, and no funds were raised from share option exercises. The company stated that all relevant corporate procedures and regulatory requirements have been duly met throughout the reporting period.